The Peptide-Drug Conjugate TH1902: A New Sortilin Receptor-Mediated Cancer Therapeutic against Ovarian and Endometrial Cancers

SIMPLE SUMMARY: Tumor heterogeneity, drug resistance, and systemic toxicity are major concerns throughout treatments of gynecological cancers. Off-target toxicity is also a significant issue with traditional cancer medicines, preventing patients’ cancers from being adequately treated with chemothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Currie, Jean-Christophe, Demeule, Michel, Charfi, Cyndia, Zgheib, Alain, Larocque, Alain, Danalache, Bogdan Alexandru, Ouanouki, Amira, Béliveau, Richard, Marsolais, Christian, Annabi, Borhane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031804/
https://www.ncbi.nlm.nih.gov/pubmed/35454785
http://dx.doi.org/10.3390/cancers14081877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031804/
https://www.ncbi.nlm.nih.gov/pubmed/35454785
http://dx.doi.org/10.3390/cancers14081877

Ejemplares similares